WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS DETERMINATION OF LEVOCETIRIZINE DIHYDROCHLORIDE AND MONTELUKAST SODIUM IN TABLET DOSAGE FORM

Noha S. Rashed*, Ola M. Abdallah and Noha S. Said

ABSTRACT

Four simple and accurate spectrophotometric methods have been described for the simultaneous determination of levocetirizine dihydrochloride and montelukast sodium in tablet dosage form. The first method is a bivariate calibration algorithm involving the use of two selected wavelengths 220 nm and 230 nm for the determination of studied drugs. The second method is a dual wavelength which is based on determination of levocetirizine dihydrochloride at the absorbance difference between 208 nm and 214.4 nm in which montelukast sodium absorbance difference was zero for any concentration, also montelukast sodium can be determined at absorbance difference between 355 and 390 nm in which levocetirizine dihydrochloride has absorbance zero for any concentration also. The third method is a derivative spectrophotometry, in which the two drugs were quantified using second derivative responses at 244 nm for levocetirizine dihydrochloride and at 293.2 or 335.6 nm for montelukast sodium. The fourth method is ratio difference which depends on measuring the peak amplitudes for levocetirizine dihydrochloride at 216 and 232 nm using 4 μg mL-1 montelukast sodium as a divisor, while montelukast sodium can be measured at 296.4 and 344.2 nm using 4 μg mL-1 of levocetirizine dihydrochloride as divisor. Beer’s law was obeyed in the concentration range 4–28 μg mL-1 for both drugs in all methods. The developed methods were used to determine the studied drugs in bulk powder, laboratory prepared mixtures and pharmaceutical dosage form with good accuracy and precision. All methods were validated according to ICH guidelines and the results obtained were statistically compared to those obtained from a reference method and were found to be in good agreement.

Keywords: Levocetrizine dihydrochloride, Montelukast sodium, Bivariate, Dual wavelength, Second derivative, Ratio difference.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More